Clinical trial NCT03337074: Paternally Inherited Phenotypes in Cholestasis
Official title: Investigation of the Effect of Raised Serum Bile Acids on the Epigenome of Sperm and the Association With the Metabolic Health of the Children of Men With Cholestasis: a Case-control Study.
Study type: OBSERVATIONAL
Overall status: UNKNOWN
Conditions: Cholestasis
Primary Sclerosing Cholangitis
Primary Biliary Cirrhosis
Lead sponsor: Guy's and St Thomas' NHS Foundation Trust
Sponsor class: OTHER
Collaborators: name: King's College Hospital NHS Trust
First posted: 2017-11-08
Enrollment: 200
Sex: ALL
Minimum age (years): 16
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Observational model: CASE_CONTROL
Time perspective: PROSPECTIVE
Sampling method: PROBABILITY_SAMPLE
Study population: Men with cholestatic liver conditions including but not restricted to Primary Sclerosing Cholangitis and Primary Biliary Cholangitis.

Fathers with cholestatic liver conditions including but not restricted to Primary Sclerosing Cholangitis and Primary Biliary Cholangitis and their children aged 16 - 25 yeas of age.

Brief summary: For some years investigators have known that the health of fathers at the time their baby is conceived has an influence on the health of their child in the future. Many studies looking at this effect have investigated fathers with obesity and other metabolic disorders. These disorders can alter the risk of obesity and diabetes in the children of these men. More recently, studies have been undertaken to establish the mechanism by which this risk is inherited by the children. Studies of sperm have identified that changes in the structure and function of the sperm play a role.

Primary Sclerosing Cholangitis (PSC) and Primary Biliary Cholangitis (PBC) are included in a group of cholestatic liver disorders that are associated with elevated levels of bile acids in the blood (cholestasis). A previous study has established that children born to women who have cholestasis during pregnancy are at an increased risk of obesity later in life. Our study will investigate whether there is a similar effect on the health of children if their father has cholestasis.

The study has 2 arms, the Sperm Epigenome arm and the Outcomes arm.

In the Sperm Epigenome arm of the study, the structure and function of sperm from men with PSC, PBC and other cholestatic liver disorders will be investigated and compared to the structure and function of sperm from healthy men.

In the Outcomes arm of the study, basic health parameters of fathers who had PSC, PBC or another cholestatic liver disease either before or after their child was conceived will be studied. Basic health parameters will also be studied in their child when the child is between 16 and 25 years of age.


Eligibility criteria: Sperm Epigenome Arm:

Cholestatic men

Inclusion Criteria:

* Men who have a diagnosis of a cholestatic liver condition including but not restricted to Primary Sclerosing Cholangitis and Primary Biliary Cholangitis.
* Me who are able and willing to give informed consent.

Exclusion Criteria:

* Men who have a history of diabetes or obesity.
* Men who have gallstones, cancer or other acute cholestatic pathology.
* Men who have a history of alcohol excess or drug abuse.
* Men who smoke.
* Men who have blood-borne viruses e.g. HIV or hepatitis.
* Men unable or unwilling to give informed consent

Healthy men

Inclusion Criteria:

* Men who have no history of cholestasis, liver disease, diabetes or obesity.
* Me who are able and willing to give informed consent.

Exclusion Criteria:

* Men who have a history of cholestasis or liver disease.
* Men who have a history of diabetes or obesity.
* Men who have a history of alcohol excess or drug abuse.
* Men who smoke.
* Men who have blood-borne viruses e.g. HIV or hepatitis.
* Men undergoing fertility treatment due to male factor.
* Men unable or unwilling to give informed consent

Outcomes Arm:

Fathers

Inclusion Criteria:

* Fathers with a cholestatic liver condition including but not restricted to Primary Sclerosing Cholangitis and Primary Biliary Cholangitis.
* Fathers with cholestatic liver condition whose children are between 16 years - 25 years of age.
* Fathers with cholestatic liver condition who are able and willing to give informed consent.

Exclusion Criteria:

* Fathers with a history of diabetes or obesity at the time of conception of their child.
* Fathers with a history of alcohol excess or drug-abuse at the time of conception of their child.
* Fathers who smoked at the time of conception of their child.
* Fathers with blood-borne viruses e.g. HIV and hepatitis at the time of conception of their child.
* Fathers unable or unwilling to give informed consent.

Children of cholestatic fathers

Inclusion Criteria:

* Adolescents / young adults (between 16 - 25 years of age) whose fathers have a cholestatic liver condition including but not restricted to Primary Sclerosing Cholangitis or Primary Biliary Cholangitis.
* Adolescents /young adults born from an uncomplicated singleton pregnancy.
* Adolescents /young adults who are able and willing to give informed consent.

Exclusion Criteria:

* Adolescents / young adults who were born as a result of multi-fetal pregnancy.
* Adolescents / young adults with a history of alcohol excess or drug-abuse.
* Adolescents / young adults who are under 16 years of age, or over 25 years of age.
* Adolescents / young adults with blood-borne viruses e.g. HIV and hepatitis.
* Adolescents / young adults who are unable or unwilling to give informed consent.

Primary outcomes:
measure: Impact of male cholestasis on DNA methylation patterns in sperm
timeFrame: 01/04/2018
measure: Impact of male cholestasis on small RNA content in sperm
timeFrame: 01/04/2018
measure: Impact of male cholestasis on sperm histone retention
timeFrame: 01/04/2018
measure: Impact of paternal cholestasis on the BMI, hip and waist girth of their adolescent / young adult children
timeFrame: 01/04/2018
measure: Impact of paternal cholestasis on the general health of their adolescent / young adult children
timeFrame: 01/04/2018
Secondary outcomes:
measure: Impact of male cholestasis on seminal fluid composition.
timeFrame: 01/04/2018
Other outcomes:
Locations:
city: London
country: United Kingdom
facility: Assisted Conception Unit, Guy's Hospital
city: London
country: United Kingdom
facility: King's College Hospital
Study officials:
References: